Inhalation Systems Market - Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast, 2013 - 2019

Nootropic products are a newly emerging category of supplements called as smart drugs aimed at enhancing brain functions and performances.

An increase in the geriatric population base worldwide, rising investments in R&D, and a deeper understanding of neurologic diseases are aiding the growth of the neurotherapeutic drugs market globally

Global active pharmaceutical ingredient market for was valued at US$ 12.9 bn in 2014, which is estimated to reach US$ 21.9 billion by 2023 at a CAGR of 6.3% from 2015 to 2023

Global Radiodermatitis Market was valued at US$299.6 mn in 2015 and is projected to expand at a CAGR of 3.9% from 2016 to 2024 to reach US$421.5 mn by 2024

Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Global market for botanical and plant derived drugs is witnessing a significant growth over recent years due to rising usage of these drugs in different parts of the world

Demands for Atherosclerosis treatment by anti-inflammatory drugs will boost the growth of Anti-Inflammatory Therapeutics Market:

Silver has a long history of use in the world of medicine due to its antimicrobial properties. Silver wound dressings come in several variants that includes sterile adhesive pads, films, bandages as well as combined wound dressings

Global Hospital Pharmaceuticals Market is expected to surge at a CAGR of 3.9% between 2015 and 2023. The market stood at US$197.3 bn in 2014 and is expected to reach US$280.3 bn by the end of 2023

Technological Advancements Boost Global Acute Ischemic Stroke Diagnosis and Treatment Market to Expand at 6.30% CAGR

Gouty arthritis is typically more common in men than in women and future damage to joints can be avoided by treatment.

Global hypertrophic cardiomyopathy therapeutics market is expected to reach US$1.37 bn in 2023, from US$1.2 bn in 2015.

Global intravenous immunoglobulin (IVIG) market, which was valued at US$7.23 bn in 2015, is projected to expand at a CAGR of 8.5% from 2016 to 2024 and reach US$14.92 bn in 2024.

The global allergy-relieving eye drops market segmented on the basis of class into antihistamines, anti-inflammatory, decongestant, mast cell stabilizers and multiple action

The market of Asia-Pacific leads in the market of Acetaminophen (Paracetamol) driven by the high growth markets of India and China

Kaposi Sarcoma Market is projected to expand at a modest 2.2% CAGR by 2024, with the opportunity in the market rising from US$118.5 mn in 2015 to be worth US$143.2 mn by 2024

Veterinary Vaccines Market is expected to expand at a healthy 6.9% CAGR by 2024. The market, which had a valuation of US$6,271.8 mn in 2015, is expected to rise to US$11,403.6 mn by 2024

Pipeline Drugs Market will reach a valuation of US$1.88 bn by 2020, rising from its 2013 valuation of US$1.28 bn. The market is expected to post a CAGR of 5.7% between 2014 and 2020

Pain management therapeutics market is expected to expand at a 3.7% CAGR by 2024; Market for pain Management is expected to rise from a valuation of US$60.2 bn in 2015 to US$83.0 bn by 2024

Pediatric drugs are categorized in three segments namely pediatric clinical pharmacology, pediatric pharmacotherapy and pediatric pharmacy

The market for pneumonia drugs and vaccines is expected to grow under the impact of drivers such as increasing aging population as aging population are more susceptible to developing pneumonia and increasing prevalence of pneumonia among children.

Mycobacteria is a large bacterial group, precisely a genus of actinobacteria, cause infections in humans. Mycobacterium infections treatment market a complete backdrop analysis, which includes an assessment of the parent market

Global Dyslipidemia Drugs Market is expected to decline to US$6.88 bn by 2023 from US$17.85 bn in 2014. Between 2015 and 2023, the global market is expected to witness a declining CAGR of -10.3%.

Human Reproductive Technologies Market (Infertility: Drugs and Procedures & Contraceptives: Drugs and Devices) - Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 – 2019

Ophthalmic Drugs Market (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018

Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Global market for rosacea therapeutics is expected to grow steadily during the forecast period 2016-2024, owing to rising awareness among people, U.S. leads Rosacea Therapeutics Market

Technological developments and improving sophistication in healthcare facilities worldwide is a major factor supporting the market growth, the global market for metastatic melanoma is more pronounced in North America

Malignant neoplasm is believed to be one of the extended conditions of neoplasm. In addition, factors such as advanced cancer diagnostics and early initiation of the treatment are fuelling the global malignant neoplasm therapeutics market

Pressure Ulcers Treatment Market is driven due to increasing awareness on treatment options among patients in developing countries, Asia Pacific will lead pressure ulcers treatment market

Decongestants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Impetigo therapeutic market is driven due to increasing awareness and low cost of its treatment, North America leads impetigo therapeutics market due to the presence of numerous drug manufacturers for impetigo treatment in the region

Alzheimers Disease Therapeutics and Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Point of Care Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018

Global market for hospital infection therapeutics to attain an opportunity worth US$3.6 bn by 2020, rising from US$3.0 bn in 2013 at a CAGR of 3.10% during the period from 2014 to 2020.

Global urgent care centers market stood at US$23.5 bn in 2013 and is predicted to reach US$30.5 bn by 2020. It is anticipated to expand at a CAGR of 3.80% from 2014 to 2020

Spurred by the increasing demand for anti-counterfeit drug packaging technologies, TMR forecasts the market to surge at a CAGR of 5.3% between 2015 and 2023

North America held the dominant share of 40.7% in the global plasma protein therapeutics market in 2015, Europe held the second largest share in the global plasma protein therapeutics market

Medical Education Market Expanding at a 4.3% CAGR by 2024, the global medical education market is poised to rise from a value of US$25.9 bn in 2015 to US$38.4 bn by 2024

Global Alcoholic Hepatitis Therapeutics Market: Alcoholic hepatitis is a kind of liver disease usually characterized by progressive inflammation of the liver due to long-term heavy intake of alcohol

Anti-cancer Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

The spending growth in the pharmerging market is expected to grow with a CAGR of 12% to 15% which will expedite the market growth in these countries

Development of genetic testing services will bring a change in various areas in healthcare sector. Majority of the genetic testing market is dominated by the U.S. market owing to higher disposable income.

Liver Diseases Therapeutics Market - Global Industry Analysis, Size, Share, Trends and Forecast 2012 – 2018

Global peptide therapeutics market will be valued at US$23.7 bn by 2020,If the projected figure hold true, the market will rise at a moderate 2.8% CAGR from 2014 to 2020.

Tuberculosis Testing Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Cancer Hormone Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023

Rise in the geriatric population, growth in the number of number of patients suffering from various forms of cancer and growing healthcare awareness among the patients are further expected to accentuate the growth of this market

Testosterone replacement therapy revenues will reach US$1.3 bn globally in 2024, down noticeably from US$2.0 bn in 2015. This translates to a (-4.2)% CAGR for the market from 2016 to 2024